Coherus Oncology, Inc. Common Stock
CHRS
CHRS
176 hedge funds and large institutions have $572M invested in Coherus Oncology, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 74 increasing their positions, 53 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
176
Holders Change
-7
Holders Change %
-3.83%
% of All Funds
2.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
74
Reduced
53
Closed
27
Calls
$3.17M
Puts
$499K
Net Calls
+$2.67M
Net Calls Change
+$3.27M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$46.2M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
$7.81M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$6.43M |
| 4 |
BlackRock
New York
|
$93.3M |
| 5 |
TLP
Tri Locum Partners
New York
|
$2.73M |
